We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$5.37M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.7M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.54M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12M
5
NVDA icon
NVIDIA
NVDA
+$1.88M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.88M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$4.62M
3
OCSL icon
Oaktree Specialty Lending
OCSL
+$825K
4
MGI
MoneyGram International, Inc. New
MGI
+$627K
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$562K

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYRX icon
2151
CryoPort
CYRX
$762M
$1.97K ﹤0.01%
114
-37
-25% -$757
MYE icon
2152
Myers Industries
MYE
$1.29B
$1.96K ﹤0.01%
101
– –
SPR
2153
DELISTED
Spirit AeroSystems
SPR
$1.96K ﹤0.01%
67
-372
-85% -$10.7K
FVRR icon
2154
Fiverr
FVRR
$339M
$1.95K ﹤0.01%
75
– –
PDS
2155
Precision Drilling
PDS
$974M
$1.95K ﹤0.01%
40
-109
-73% -$5.2K
FN icon
2156
Fabrinet
FN
$20.1B
$1.95K ﹤0.01%
15
-34
-69% -$3.63K
ENTA icon
2157
Enanta Pharmaceuticals
ENTA
$400M
$1.95K ﹤0.01%
91
+80
+727% +$2.36K
MBUU icon
2158
Malibu Boats
MBUU
$567M
$1.94K ﹤0.01%
33
+5
+18% +$281
ABUS icon
2159
Arbutus Biopharma
ABUS
$915M
$1.92K ﹤0.01%
833
– –
GNK icon
2160
Genco Shipping & Trading
GNK
$1.1B
$1.91K ﹤0.01%
136
-197
-59% -$2.83K
PRG icon
2161
PROG Holdings
PRG
$1.71B
$1.9K ﹤0.01%
59
– –
VISN
2162
Vistance Networks Inc
VISN
$2.52B
$1.89K ﹤0.01%
336
-290
-46% -$1.39K
PHAT icon
2163
Phathom Pharmaceuticals
PHAT
$692M
$1.89K ﹤0.01%
+132
New +$1.52K
MTTR
2164
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$1.89K ﹤0.01%
600
+210
+54% +$582
BHE icon
2165
Benchmark Electronics
BHE
$2.96B
$1.89K ﹤0.01%
73
+34
+87% +$786
OOMA icon
2166
Ooma
OOMA
$604M
$1.89K ﹤0.01%
+126
New +$1.66K
LBTYK icon
2167
Liberty Global Class C
LBTYK
$3.49B
$1.88K ﹤0.01%
106
– –
RLAY icon
2168
Relay Therapeutics
RLAY
$4.33B
$1.88K ﹤0.01%
150
+22
+17% +$274
TLRY icon
2169
Tilray
TLRY
$622M
$1.88K ﹤0.01%
120
– –
TR icon
2170
Tootsie Roll Industries
TR
$2.98B
$1.88K ﹤0.01%
58
-12
-17% -$438
GLNG icon
2171
Golar LNG
GLNG
$5.13B
$1.88K ﹤0.01%
93
– –
STER
2172
DELISTED
Sterling Check Corp. Common Stock
STER
$1.86K ﹤0.01%
152
-374
-71% -$4.48K
CRUS icon
2173
Cirrus Logic
CRUS
$6.26B
$1.86K ﹤0.01%
23
– –
SMMT icon
2174
Summit Therapeutics
SMMT
$11.1B
$1.86K ﹤0.01%
740
-3,426
-82% -$6.25K
CNM icon
2175
Core & Main
CNM
$8.71B
$1.85K ﹤0.01%
59
– –
85 86
87
88 89

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.